DNLI Operating Expenses

Denali Therapeutics Inc · Operating Expenses

DNLI logo

DNLI Operating Expenses

Latest reported$540.50M
DNLI Operating Expenses ($16.68M → $540.50M)
High-resolution chart · PNG

DNLI operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
544,159,000
487,341,000
527,230,000
449,207,000
344,412,000
272,941,000
239,862,000
175,532,000
90,140,000
87,433,000
16,679,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.